Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of ...

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement ...

EcoSynthetix Inc. (TSE:ECO – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$4.21 and traded as high as C$5.14.

We recently compiled a list of the 10 Micro and Small-Cap Firms Drive Year-to-Date Gains. In this article, we are going to take a look at where Rapid Micro Biosystems, Inc.

Chardan raised the firm’s price target on Solid Biosciences (SLDB) to $16 from $15 and keeps a Buy rating on the shares. The company has ...

Arcus Biosciences shares were down 14%, to $11.33, after the company priced a $150 million stock offering. Shares of the biopharmaceutical company hit their 52-week low of $10.65 earlier in the ...

WeRide (NASDAQ: WRD) stock has surged significantly late last week. It reached an intraday high of 146% before it closed up 83.46% at $31.5. Why did WRD stock rise so much? Should you still buy the ...

Shares of iBio Inc. IBIO rose 7.29% to $3.68 Tuesday, on what proved to be an all-around favorable trading session for the ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...